02/14/2025 4:16 PM | Anson Funds Management LP (Filed by) TransCode Therapeutics (Subject)
| Form SCHEDULE 13G | |
02/04/2025 3:20 PM | TransCode Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/04/2025 3:21 PM | TransCode Therapeutics (Filer)
| Form DEFA14A | |
01/03/2025 6:25 PM | SABBY MANAGEMENT, LLC (Filed by) TransCode Therapeutics (Subject)
| Form SCHEDULE 13G | |
12/30/2024 4:08 PM | TransCode Therapeutics (Filer)
| Form DEF 14A | |
12/19/2024 3:48 PM | TransCode Therapeutics (Filer)
| Form PRE 14A | |
12/17/2024 11:15 PM | TransCode Therapeutics (Filer)
| Form EFFECT | |
12/12/2024 3:15 PM | TransCode Therapeutics (Filer)
| Form D Notice of Exempt Offering of Securities | |
12/06/2024 4:05 PM | TransCode Therapeutics (Filer)
| Form S-1 Registration statement under Securities Act of 1933 | |
12/02/2024 3:27 PM | TransCode Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/29/2024 3:21 PM | TransCode Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for RNAZ and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for TransCode Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
|
11/25/2024 6:54 AM | TransCode Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/13/2024 3:34 PM | TransCode Therapeutics (Filer)
| Form DEFA14A | |
11/06/2024 3:05 PM | 3i, LP (Filed by) TransCode Therapeutics (Subject)
| Form SC 13G/A | |
10/28/2024 3:02 PM | TransCode Therapeutics (Filer)
| Form DEF 14A | |
10/15/2024 4:23 PM | TransCode Therapeutics (Filer)
| Form PRE 14A | |
09/27/2024 3:02 PM | TransCode Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/28/2024 5:02 AM | TransCode Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/16/2024 4:04 PM | TransCode Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/14/2024 3:45 PM | TransCode Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
07/24/2024 8:01 AM | TransCode Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/24/2024 7:18 AM | TransCode Therapeutics (Filer)
| Form 424B5 | |
07/22/2024 3:10 PM | TransCode Therapeutics (Filer)
| Form 424B5 | |
06/14/2024 7:00 AM | TransCode Therapeutics (Filer)
| Form 8-K/A | |
06/13/2024 4:06 PM | TransCode Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/10/2024 7:45 AM | TransCode Therapeutics (Filer)
| Form DEFA14A | |
05/13/2024 4:08 PM | TransCode Therapeutics (Filer)
| Form DEFA14A | |
05/10/2024 3:45 PM | TransCode Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/05/2024 3:51 PM | TransCode Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |